Software to predict the right dose for vancomycin in a clinical environment-A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi-experimental study by Luqman Vali et al
- PMID: 33638868
- PMCID: PMC8451928
- DOI: 10.1111/bcp.14765
Software to predict the right dose for vancomycin in a clinical environment-A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi-experimental study by Luqman Vali et al
Conflict of interest statement
There are no competing interests to declare.
Comment on
-
Personalised dosing of vancomycin: A prospective and retrospective comparative quasi-experimental study.Br J Clin Pharmacol. 2021 Feb;87(2):506-515. doi: 10.1111/bcp.14411. Epub 2020 Jun 30. Br J Clin Pharmacol. 2021. PMID: 32495366
References
-
- Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adults: summary of consensus recommendations from the American Society of Health‐System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2009;29(11):1275‐1279. 10.1592/phco.29.11.1275 - DOI - PubMed